Abstract
Abstract
Background
Physical inactivity is a main cause of childhood obesity which tracks into adulthood obesity, making it important to address early in life. Physical activity on prescription (PAP) is an evidence-based intervention that has shown good effect on physical activity levels in adults, but has not been evaluated in children with obesity. This project aims to evaluate the prerequisites, determinants, and feasibility of implementing PAP adapted to children with obesity and to explore children’s, parents’, and healthcare providers’ experiences of PAP.
Methods
In the first phase of the project, healthcare providers and managers from 26 paediatric clinics in Region Västra Götaland, Sweden, will be invited to participate in a web-based survey and a subset of this sample for a focus group study. Findings from these two data collections will form the basis for adaptation of PAP to the target group and context. In a second phase, this adapted PAP intervention will be evaluated in a clinical study in a sample of approximately 60 children with obesity (ISO-BMI > 30) between 6 and 12 years of age and one of their parents/legal guardians. Implementation process and clinical outcomes will be assessed pre- and post-intervention and at 8 and 12 months’ follow-up. Implementation outcomes are the four core constructs of the Normalization Process Theory; coherence, cognitive participation, collective action, and reflexive monitoring; and appropriateness, acceptability, and feasibility of the PAP intervention. Additional implementation process outcomes are recruitment and attrition rates, intervention fidelity, dose, and adherence. Clinical outcomes are physical activity pattern, BMI, metabolic risk factors, health-related quality of life, sleep, and self-efficacy and motivation for physical activity. Lastly, we will explore the perspectives of children and parents in semi-structured interviews. Design and analysis of the included studies are guided by the Normalization Process Theory.
Discussion
This project will provide new knowledge regarding the feasibility of PAP for children with obesity and about whether and how an evidence-based intervention can be fitted and adapted to new contexts and populations. The results may inform a larger scale trial and future implementation and may enhance the role of PAP in the management of obesity in paediatric health care in Sweden.
Trial registration
ClinicalTrials.gov Identifier: NCT04847271, registered 14 April 2021.
Funder
Forskningsrådet om Hälsa, Arbetsliv och Välfärd
University of Gothenburg
Publisher
Springer Science and Business Media LLC
Reference79 articles.
1. NCD Risk Factor Collaboration. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627–42.
2. Garrido-Miguel M, Cavero-Redondo I, Alvarez-Bueno C, Rodriguez-Artalejo F, Moreno LA, Ruiz JR, et al. Prevalence and trends of overweight and obesity in European children from 1999 to 2016: a systematic review and meta-analysis. JAMA Pediatr. 2019;173(10):e192430.
3. World Health Organization. Global health observatory 2020. Available from: https://www.who.int/data/gho/data/themes/theme-details/GHO/body-mass-index-(bmi). Accessed 14 Mar 2021.
4. Public Health Agency of Sweden. Overweight and obesity are common and increase with age in 6-9 year olds [Internet]. Report no. 20100. 2020. Available from: https://www.folkhalsomyndigheten.se/publicerat-material/publikationsarkiv/oe/overvikt-och-fetma-ar-vanligt-och-okar-med-alder-hos-6-9-aringar. Accessed 8 Apr 2021.
5. Public Health Agency of Sweden. Annual report 2019. Available from: https://www.folkhalsomyndigheten.se/contentassets/d162673edec94e5f8d1da1f78e54dac4/folkhalsans-utveckling-arsrapport-2019.pdf. Accessed 29 Jan 2021.